Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

OUHSC Research News – Monday, January 10, 2022

OUHSC Research News – Monday, January 10, 2022


Notices and Reminders

Effective October 1st, the NIH requires all NIH-funded clinical trials to complete clinical trial registration 21 days after enrollment of first participant and/or results reporting 12 months after trial actual primary completion date.  NIH has now enhanced checks on non-compliance for these two requirements in the eRA System.  Failure to comply with NIH timeline will delay your Research Performance Progress Report (RPPR) submission.  NIH has also placed additional scrutiny on all aspects of RPPRs that has resulted in a significant increase in rejected reports from OUHSC investigators.

Because of these substantial changes and additional information requirements (including Other Support format), all RPPRs are now subject to additional review by ORA.

Effective January 1, 2022, ORA MUST receive RPPRs for review 3 business days prior to the sponsor deadline for single-project grants and 5 business days prior to the sponsor deadline for multi-project grants.

For more information on NIH enhanced checks on non-compliance, please see:


We are fast approaching NIH January Deadline (i.e. January 25, 2022). Your assistance in notifying us of your intention to submit a proposal for the upcoming deadline and submitting the final proposal package according to the ORA proposal submission policy will help ensure a smooth and successful submission.


ORA Reminder: Effective October 1st, ORA requires applicants and recipients to use the updated Other Support format to submit with applications, Just-In-Time (JIT) and Research Performance Progress Reports (RPPRs). 

Because of the substantial changes and additional information that needs to be included, all Key Personnel on RPPRs are expected to provide Other Support in the updated format for each RPPR, regardless of when Other Support was last submitted for key personnel. Failure to follow the appropriate format on or after October 1st, may delay processing your application/award by the ORA staff.


Requirements for Acknowledging NIH-Supported Research

NIH funded researchers are required to accurately acknowledge NIH funding in publications, press releases, or other documents about research that is funded by NIH in whole or in part. To comply with NIH requirements, recipients must include the following (as described in Communicating and Acknowledging Federal Funding):

Recipients should only acknowledge NIH awards on publications and other documents when the research activities that contributed to that publication directly arise from the award and are within the scope of the award being acknowledged. Please see the Communicating and Acknowledging Federal Funding and FAQs pages for more information on when, where, and how to acknowledge NIH funding. 


VPR Staff Editor

Kathy Kyler is the staff editor for the OUHSC campus. Her assistance is available on request without

charge through the office of the Vice President for Research. You can contact her by e-mail at or by calling ORA at 271-2090. Please allow sufficient time for review.

In general, turnaround time is 7 business days for manuscripts and 5 business days for grant

proposals of 12 pages or less for the research plan.


Workshops and Seminars

NSF EPSCoR Professional Development Seminar Series: Getting the Most from Your Team's Science

Date: 1/24/22, 12:00-1:00 p.m. (Central)

Description: Faculty, postdoctoral researchers, and university students interested in pursuing a career in research are invited to participate in the Oklahoma NSF EPSCoR Professional Development Seminar Series. The first seminar of 2022, “Getting the Most from Your Team’s Science,” has been scheduled for Monday, January 24, from noon to 1:00 p.m. (Central Time). The meeting will be presented via Zoom by Dr. L. Michelle Bennett, Director, Center for Research Strategy, National Cancer Institute, and Chief Innovation Officer, Acting, National Institute of Environmental Health.

Login Information:


OUHSC Funding Opportunities

Presbyterian Health Foundation Research Grants Program - 2022

Deadline: various -please see the table below

Description: This grant program funds multiple types of projects and has enabled the progression of pioneering concepts to research studies, the establishment of renowned clinicians and basic scientists transdisciplinary teams unifying a broad range of expertise and skills, the development of extremely talented junior faculty, the provision of infrastructure support for faculty to continue ground-breaking research, and more.

Click here to learn more about the 2022 opportunities.

If you have any questions, please email

Link to Full Announcement:


Grant Type



February 25, 2022

Research Support

February 25, 2022


February 25, 2022


March 4, 2022

New Investigator Seed

(Requires nomination by College)

March 11, 2022

Clinician Scientist Development

March 11, 2022

Team Science

March 25, 2022


April 1, 2022


Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email or  

  • Bayer Crop Science is interested in collaborating with academia to identify novel and/or engineered protein candidates that can be produced in plant cell cultures or transformed plant systems for applications in food, agriculture, sustainability, consumer health, pharmaceuticals or other industries.  Out of scope: products with a small potential market.  Submission entails a 1-pg non-confidential summary of technology (deadline 1/12).
  • Roivant Sciences is seeking key opinion leaders/advisors to collaborate in developing a universal influenza vaccine program based on differentiated RNA technology.  Areas of interest include delivery systems for RNA, adjuvants, and modified nucleosides.  RNA-based technologies that have no potential application to respiratory diseases are out of scope.   Submission entails a 1-pg non-confidential summary of technology (deadline 1/12).
  • A materials science company (requested anonymity) is interested in collaborative opportunities to develop technologies for the immobilization of live non-mammalian organisms for use in fermentation.  Of special interest are substrates for biofilm formation, bioreactor technologies, and methods to increase useable cell densities.  Out of scope: approaches for water treatment application, technologies leveraging small geometry substrates.  Submission entails a 1-pg non-confidential summary of technology (deadline 1/19).
  • A digital microsensors company (requested anonymity) is searching for technologies related to adsorption-based sensors for measuring carbon dioxide concentration in ambient air.  The technology should be optimized for low production cost.  At minimum, technology should be at the prototyping stage.  Submission entails a 1-pg non-confidential summary of technology (deadline 2/2).


NIH Notices 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless  otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.


NIH Funding Opportunities

Other Funding Opportunities

The Keck Foundation Research Program

Description: The Keck Foundation is requesting applications for funding for their 2022 grant cycle. The priorities of the foundation focus on important and emerging areas of research. The application must have the potential to develop breakthrough technologies, instrumentation or methodologies, are innovative, distinctive and interdisciplinary, demonstrate a high level of risk due to unconventional approaches, or by challenging the prevailing paradigm, and have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or by altering the perception of a previously intractable problem. The project should not concentrate on clinical or translational research or research for the sole purpose of drug development. Generally, these projects fall outside the domain of public funding agencies. For more information please refer to the Keck Foundation website. Awards are generally $1,000,000.

Applications are due May 1st, 2022 but a preproposal counseling period is open from January 1st  to February 15th, 2022. Only one application is permitted per institution and, if you are interesting in submitting a project, please email William Sonntag, PhD ( no later than January 14th  to set up a time to discuss the proposal. Participation in the Preproposal Counseling Session with the Keck Foundation will be required and involves the development of a 1 page concept paper.


Southwest National Primate Research Center (SNPRC) Pilot Research Program 2022 Competition

Description: The SNPRC Pilot Research program provides opportunities and support for investigators to use SNPRC nonhuman primate resources in highly focused, short-term studies with a high likelihood of enhancing the value, utility, feasibility, and attractiveness of nonhuman primates for biomedical research. High priority will be given to studies that propose to generate preliminary data for applications to the National Institutes of Health (NIH) for support of future research projects. Those proposing to develop new nonhuman primate models of disease, or develop and/or test new research methods, instrumentation, or approaches for biomedical research using nonhuman primates, also will be considered responsive to the goals of the program.

LOIs Due: February 4, 2022

Full proposals (with invitation only) Due: March 25, 2022

Link to Full Announcement:


American Heart Association (AHA) Mechanisms Underlying Cardiovascular Consequences
Associated with COVID-19 and Long COVID

Description: The American Heart Association (AHA) is accepting research proposals to better understand the mechanism(s) underlying cardiac, vascular and cerebrovascular effects of COVID-19 and Long COVID, as well as mechanisms that contribute to differential susceptibility to Long COVID. Because of the racial and ethnic disparities associated with COVID-19 and Long COVID, proposals should have a strong focus on inclusion of demographically diverse subject populations.

Proposals Due: February 1, 2022, 3pm CST

Link to Full Announcement:



Description: To identify and respond to emerging opportunities to transform and improve the health of

Oklahomans, TSET will accept unsolicited proposals in two areas of emphasis. Proposals must identify immediate, impactful opportunities to positively transform and improve the health of Oklahomans. Proposals must be project-driven, time-limited, have a specific targeted area or population in mind, be supported by multiple partners, and agree to participate in an external evaluation of the project.

Unsolicited proposals are accepted for projects related to the following areas identified as priorities by the TSET Board of Directors:

  1. Policy and built environment change: up to $350,000 per project per year for up to two years
  2. Innovations in active living and healthy eating: up to $250,000 per project per year for up to two years

Proposals Due: March 15, 2022

Link to Full Announcement:


NIH technology accelerator challenge for maternal health

Description: The National Institute of Biomedical Imaging and Bioengineering (NIBIB), with the support of its partners, is offering up to $1,000,000 in cash prizes for innovative diagnostic technologies to help improve maternal health around the world.

The NIH Technology Accelerator Challenge for Maternal Health (NTAC: Maternal Health) seeks to spur and reward the development of prototypes for low-cost, point-of-care molecular, cellular, and/or metabolic sensing and diagnostic technologies to guide rapid clinical decision-making, improve patient outcomes, and ultimately prevent maternal morbidity and mortality.

To win NTAC: Maternal Health, participants must: (1) Submit their design for a point-of-care diagnostic test or platform technology with initial feasibility data or references addressing at least two of the four priority conditions listed below affecting maternal health during antenatal and intrapartum periods; and (2) Submit a robust description of the proposed path for translation and further development of the diagnostic technology for use in global health settings. Additionally, diagnostics should be fully integrated digital health platforms. The four priority conditions and specific examples are as follows:

  • Infection: viral, bacterial, or parasitic infections; sepsis; post-procedural infections
  • Hypertensive disease: pre-eclampsia; eclampsia
  • Hemorrhage: acute anemia; iron deficiency anemia; coagulopathy
  • Placental issues: angiogenic or other markers of placental disruption

Proposals Due: April 1, 2022

Link to Full Announcement:


Telligen Community Initiative (TCI) philanthropy - 2022 REQUEST FOR PROPOSALS

Description: Grants of up to $50,000 to Illinois, Iowa, Colorado, and Oklahoma nonprofits, schools, and agencies for programs that support creative ways to bring innovation and equity to the health sector and recruiting and generating pathways to a high-quality health care workforce. Programs can also emphasize novel approaches to positively address the social determinants of health.

All current TCI grants are for periods of one year.  Cycle 1 awardees (OK or CO) begin on June 1, 2022. 

Proposals Due: February 28, 2022

Link to Full Announcement:


OKLAHOMA NSF EPSCoR Research Seed Grant Funding Opportunity

Description: The Oklahoma NSF EPSCoR program is announcing the availability of funding to stimulate high-risk, high-impact, and potentially transformative research to develop and test science-based solutions for complex (“wicked”) problems at the intersection of land use, water availability, and infrastructure in OK. Seed Grant proposals will be accepted by OK NSF EPSCoR from any Oklahoma institution of higher education. Funding will be awarded for projects of up to 1-year duration. The maximum award amount for a single award is $75,000; however, smaller proposals are encouraged.

Proposals Due: January 15, 2022 

Link to Full Announcement:


Cystic Fibrosis Foundation 

Clinical Research Award and Clinical Pilot and Feasibility Award: Full application (Invite-Only) deadline January 25, 2022.

First and Second Year Clinical Fellowships - Application deadlines March 2, 2022

Third and Fourth Year Clinical Fellowships - Application deadlines: February 16, 2022

Fifth+ Year Clinical Fellowships - Application deadlines: February 16, 2022

LeRoy Matthews Physician-Scientist Award - Application deadlines: February 16, 2022

Harry Shwachman Clinical Investigator Award - Application deadlines: February 16, 2022

Additional Open Funding Opportunities can be found here.  


Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP)

Fiscal Year 2022 (FY22) pre-announcements

Ovarian Cancer Research Program (OCRP)


  • Investigator - Initiated Research Award
  • Ovarian Cancer Academy Award - Early-Career Investigator
  • Pilot Award
  • Teal Expansion Award
  • Proteogenomics Research Award
  • Omics Cancer Academy - Clinical Trial Award
  • Clinical Trial Award

Tuberous Sclerosis Complex Research Program (TSCRP) (

  • Exploration – Hypothesis Development Award
  • Idea Development Award   
  • Clinical Translational Research Award


The International Foundation for Ethical Research (IFER) – 2022-2023 GRADUATE FELLOWSHIPS FOR ALTERNATIVES TO THE USE OF ANIMALS IN SCIENCE

Description: IFER Graduate Fellowships are one-year grants for projects that support the development, acceptance and implementation of innovative scientific methodologies that advance science and refine, reduce or replace the use of animals in research, testing or education. Grants of $12,500 are typically awarded and are renewable annually for up to three years, depending on student progress and availability of funds. IFER recognizes the value in directing financial resources away from animal models and toward the development of human-relevant, non-animal models, as such resources pay higher dividends for human health when used for human-relevant research.

Pre-proposals Due: April 30, 2022

Link to Full Announcement: More information on the IFER Graduate Fellowship program, including eligibility requirements, submission guidelines, and a link to the online application can be found on the IFER website at


The Mselanoma Research Alliance (MRA) 2021-2022 Request for Proposal

Team Science Award Full Proposals Due (from invited applicants) Due: January 19, 2022

Description: MRA anticipates supporting at least $12.8 million in new funding. Proposals will be accepted for Team Science, Academic-Industry Partnership, Young Investigator, and Pilot Awards. Special Opportunities are also available in immunotherapy, women in research, and patient-centric clinical trials. MRA encourages applications from a diverse pool of investigators. Full descriptions of each award opportunity offered, including all Special Opportunity Awards, as well as eligibility criteria and instructions can be found on the MRA website at 

Proposals should be submitted via the proposalCENTRAL online application tool:




Documents to download